跳到正文
原文
Medical Xpress·· 2026-10-13AI 评分36

研究提供新线索:APOE4 的脂质携带状态如何影响阿尔茨海默病相关小胶质细胞

Study offers new clues about how genetic risk for Alzheimer's affects brain immune cells

AI 导读

University of Colorado Anschutz 与 Pacific Northwest National Laboratory 团队在《Alzheimer's & Dementia》报告,APOE4 是否携带脂质会以不同方式改变人小胶质细胞的脂质储存与炎症反应。

正文
Study offers new clues about how genetic risk for Alzheimer's affects brain immune cells
Lipid-free ApoE4 leads to increased lipid-droplet accumulation, whereas reconstituted high-density lipoprotein (HDL)-like particles (rHDL) lead to enhanced lipid (POPC) uptake by primary microglia. Credit: Alzheimer's & Dementia (2026). DOI: 10.1002/alz.71882

Researchers at the University of Colorado Anschutz and Pacific Northwest National Laboratory have found a new clue that may help explain why some people are more likely to develop Alzheimer's disease. It suggests that a protein linked to the disease can change how the brain's immune cells handle fat and trigger inflammation. Those changes could help explain how a well-known genetic risk factor for Alzheimer's affects the brain.

The study was published this week in Alzheimer's & Dementia.

The gene is called APOE, and one version, APOE4, is the strongest genetic risk factor for Alzheimer's disease. But having APOE4 does not mean someone will develop Alzheimer's. Scientists have spent decades trying to understand why.

"Our brains are mostly made of fat. But because fat can't get into the brain from the circulation, the brain has to make its own fat. It does this by sending fat-carrying particles from one cell to another. This movement of fat around the brain keeps the cells healthy.

"ApoE acts like a belt holding these particles together. Our findings suggest that the way ApoE4 carries lipids causes cells to hang on to the fat, breaking the fat cycle and causing cells to become very inflamed," said Kimberley D. Bruce, Ph.D., senior author of the study and an associate professor in endocrinology at the CU Anschutz School of Medicine.

What the researchers found

The researchers studied microglia, the brain's immune cells.

"Microglia are so important in the fight against Alzheimer's disease. Think of these cells like the brain's cleanup and security crew. They help remove damaged material, watch for problems and respond when something goes wrong. When these cells aren't able to perform these roles correctly, the brain loses its fight against Alzheimer's disease," said Bruce.

The team exposed human microglia to different forms of the ApoE protein. "When microglia were treated with ApoE4, they stored fat differently, developing fewer but larger fat droplets," said Tsion Shiferaw, M.Sc., a research professional at CU Anschutz and first author of the study. "They also had fewer mitochondria, the parts of cells that help turn fat into energy."

Another important finding was that the protein's effects on the cells depended on whether it was carrying fat or whether it was fat-free. When ApoE4 was carrying fat, it changed how the cells stored and used fat and energy. When it was not carrying fat, it triggered a stronger immune response associated with inflammation. In other words, what the protein was carrying appeared to influence how the brain's immune cells behaved.

Why this matters

Scientists already know that APOE4 increases a person's risk of Alzheimer's. What they don't know as well is how that risk actually plays out inside the brain. This study points to one possible answer.

The way ApoE4 handles fat may help determine whether the brain's immune cells change how they use energy or become more inflammatory. That matters because inflammation and changes in how brain cells use and store fat have both been linked to Alzheimer's disease.

The findings could give scientists a new way to study why APOE4 increases Alzheimer's risk and, eventually, whether those effects can be prevented or changed.

"Our findings suggest that ApoE4 can affect microglia in different ways depending on whether it is carrying fat," Bruce said. "In the future, we should be thinking about ways to make ApoE4 carry more fat to preserve the function of these important (microglia) cells. We should also explore treatments that can block the specific type of inflammation that fat-free ApoE4 seems to trigger to reduce Alzheimer's disease risk in people who carry the ApoE4 gene."

It's important to note that the study does not show that APOE4 causes Alzheimer's disease, and it does not provide a new treatment.

The researchers studied human brain immune cells in the laboratory. More work is needed to find out whether the same changes happen in people and whether they contribute to the development of Alzheimer's disease.

Publication details

Tsion G. Shiferaw et al., ApoE lipidation state directs immunometabolic reprogramming of human microglia, Alzheimer's & Dementia (2026). DOI: 10.1002/alz.71882

Journal information: Alzheimer's & Dementia

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Study offers new clues about how genetic risk for Alzheimer's affects brain immune cells (2026, October 12) retrieved 12 October 2026 from https://medicalxpress.com/news/2026-10-clues-genetic-alzheimer-affects-brain.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com